These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 36211804)

  • 1. Tremor in Parkinson's Disease: From Pathophysiology to Advanced Therapies.
    Abusrair AH; Elsekaily W; Bohlega S
    Tremor Other Hyperkinet Mov (N Y); 2022; 12():29. PubMed ID: 36211804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.
    Pirker W; Katzenschlager R; Hallett M; Poewe W
    J Parkinsons Dis; 2023; 13(2):127-144. PubMed ID: 36847017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-dopaminergic treatments for motor control in Parkinson's disease.
    Fox SH
    Drugs; 2013 Sep; 73(13):1405-15. PubMed ID: 23917951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.
    Dirkx MF; Zach H; van Nuland A; Bloem BR; Toni I; Helmich RC
    Brain; 2019 Oct; 142(10):3144-3157. PubMed ID: 31509182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus.
    Dirkx MF; den Ouden HE; Aarts E; Timmer MH; Bloem BR; Toni I; Helmich RC
    Brain; 2017 Mar; 140(3):721-734. PubMed ID: 28073788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tremor-predominant Parkinson's disease. Approaches to treatment.
    Marjama-Lyons J; Koller W
    Drugs Aging; 2000 Apr; 16(4):273-8. PubMed ID: 10874522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
    Tarsy D; Scollins L; Corapi K; O'Herron S; Apetauerova D; Norregaard T
    Stereotact Funct Neurosurg; 2005; 83(5-6):222-7. PubMed ID: 16534254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Parkinson's disease: what is the best approach to treatment.
    Hristova AH; Koller WC
    Drugs Aging; 2000 Sep; 17(3):165-81. PubMed ID: 11043817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.
    Deuschl G; Antonini A; Costa J; Śmiłowska K; Berg D; Corvol JC; Fabbrini G; Ferreira J; Foltynie T; Mir P; Schrag A; Seppi K; Taba P; Ruzicka E; Selikhova M; Henschke N; Villanueva G; Moro E
    Mov Disord; 2022 Jul; 37(7):1360-1374. PubMed ID: 35791767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's Disease: A Review from Pathophysiology to Treatment.
    Marino BLB; de Souza LR; Sousa KPA; Ferreira JV; Padilha EC; da Silva CHTP; Taft CA; Hage-Melim LIS
    Mini Rev Med Chem; 2020; 20(9):754-767. PubMed ID: 31686637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Parkinson's disease with multiple drugs].
    Kuno S
    Nihon Rinsho; 1997 Jan; 55(1):59-64. PubMed ID: 9014424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connectivity derived thalamic segmentation in deep brain stimulation for tremor.
    Akram H; Dayal V; Mahlknecht P; Georgiev D; Hyam J; Foltynie T; Limousin P; De Vita E; Jahanshahi M; Ashburner J; Behrens T; Hariz M; Zrinzo L
    Neuroimage Clin; 2018; 18():130-142. PubMed ID: 29387530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of essential tremor and Parkinson's disease.
    Uitti RJ
    Geriatrics; 1998 May; 53(5):46-8, 53-7. PubMed ID: 9597979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of disabling tremor.
    Schadt CR; Duffis EI; Charles PD
    Expert Opin Pharmacother; 2005 Mar; 6(3):419-28. PubMed ID: 15794733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tremor and dopamine agonists.
    Elble RJ
    Neurology; 2002 Feb; 58(4 Suppl 1):S57-62. PubMed ID: 11909986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Botulinum Toxin on Hand Tremor Intensity and Upper Limb Function in Patients with Parkinson's Disease: Results of a Systematic Review.
    Eslamian F; Dolatkhah N; Fallah L; Jahanjoo F; Toopchizadeh V; Talebi M
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():27. PubMed ID: 37637849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic relevant functional reactivity is associated with dopamine responsiveness of tremor in Parkinson's disease.
    Wu J; Zhou C; Guo T; Guan X; Gao T; Bai X; Wu H; Chen J; Wen J; Liu X; Gu L; Song Z; Xuan M; Gu Q; Huang P; Pu J; Zhang B; Xu X; Zhang M
    Brain Imaging Behav; 2022 Jun; 16(3):1234-1245. PubMed ID: 34973120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies.
    Deuschl G; Antonini A; Costa J; Śmiłowska K; Berg D; Corvol JC; Fabbrini G; Ferreira J; Foltynie T; Mir P; Schrag A; Seppi K; Taba P; Ruzicka E; Selikhova M; Henschke N; Villanueva G; Moro E
    Eur J Neurol; 2022 Sep; 29(9):2580-2595. PubMed ID: 35791766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cerebral Network of Parkinson's Tremor: An Effective Connectivity fMRI Study.
    Dirkx MF; den Ouden H; Aarts E; Timmer M; Bloem BR; Toni I; Helmich RC
    J Neurosci; 2016 May; 36(19):5362-72. PubMed ID: 27170132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.